Found: 9
Select item for more details and to access through your institution.
Letter to the Editor: Repurposing of an Antisepsis Drug in COVID-19 Patients.
- Published in:
- Assay & Drug Development Technologies, 2021, v. 19, n. 7, p. 407, doi. 10.1089/adt.2020.994
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications April–June 2021.
- Published in:
- Assay & Drug Development Technologies, 2021, v. 19, n. 7, p. 463, doi. 10.1089/adt.2021.095
- By:
- Publication type:
- Article
Utilization of an Intracellular Calcium Mobilization Assay for the Screening of Transduced FK506-Binding Proteins.
- Published in:
- Assay & Drug Development Technologies, 2021, v. 19, n. 7, p. 442, doi. 10.1089/adt.2021.065
- By:
- Publication type:
- Article
Letter to the Editor: Implementation of Acoustic Dispensing and 384-Well Based Workflows to Improve Assay Capacity and Reduce Compound and Solvent Use in Early Drug Metabolism and Pharmacokinetics Profiling.
- Published in:
- Assay & Drug Development Technologies, 2021, v. 19, n. 7, p. 410, doi. 10.1089/adt.2021.062
- By:
- Publication type:
- Article
Nano Spray-Dried Drugs for Oral Administration: A Review.
- Published in:
- Assay & Drug Development Technologies, 2021, v. 19, n. 7, p. 412, doi. 10.1089/adt.2021.053
- By:
- Publication type:
- Article
Call for Special Issue Papers: Chemical Probes and Pharmacological Tools for Kinase Signaling: Deadline for Manuscript Submission: December 1, 2021.
- Published in:
- Assay & Drug Development Technologies, 2021, v. 19, n. 7, p. 405, doi. 10.1089/adt.2020.29096.cfp2
- By:
- Publication type:
- Article
Antifungal Effects of Voriconazole-Loaded Nano-Liposome on Fluconazole-Resistant Clinical Isolates of Candida albicans, Biological Activity and ERG11, CDR1, and CDR2 Gene Expression.
- Published in:
- Assay & Drug Development Technologies, 2021, v. 19, n. 7, p. 453, doi. 10.1089/adt.2020.1057
- By:
- Publication type:
- Article
Call for Special Issue Papers: Special Issue on High-throughput Technologies for the Discovery and Development of Chemical Probes and Pharmacological Tools: Deadline for Manuscript Submission: November 1, 2021.
- Published in:
- Assay & Drug Development Technologies, 2021, v. 19, n. 7, p. 403, doi. 10.1089/adt.2020.29095.cfp2
- By:
- Publication type:
- Article
Re: "Letter to the Editor: Repurposing of an Antisepsis Drug in COVID-19 Patients," by Kumar et al.
- Published in:
- Assay & Drug Development Technologies, 2021, v. 19, n. 7, p. 408, doi. 10.1089/adt.2020.1002
- By:
- Publication type:
- Article